文振华，男，主任医师，硕士，硕士生导师，中南大学湘雅bat365标准版附属株洲医院风湿免疫科主任，疑难罕见病中心副主任。 2007年6月七年制本硕连读毕业于中南大学湘雅bat365标准版。研究兴趣：1. 风湿免疫病及疑难罕见病的诊治；2、临床队列研究；3、药物经济学研究。讲授《临床思维概述 》、《风湿免疫病概论》等课程。主持并完成湖南省自然科学青年基金项目1项，参与中华国际交流基金1项，以第一作者或通讯作者发表核心期刊论文20余篇，作为主编和副主编出版专著两部，2017年获“中国风湿免疫科临床实践精英挑战赛”全国总冠军。
联系方式：151728544@qq.com
代表性成果
1、Yu S, Deng L, Wang G, Li J, Wang J, Wen Z. Kimura's disease presenting as a posterior mediastinal mass complicated with relapsing polychondritis. Rheumatology (Oxford). 2022 Mar 2;61(3):e67-e68.
2、Chen LJ, Zhou YJ, Wen Z, Tian F, Li JY. Efficacy and safety of iguratimod combined with methotrexate vs. methotrexate alone in rheumatoid arthritis : A systematic review and meta-analysis of randomized controlled trials. Z Rheumatol. 2021 Jun;80(5):432-446.
3、Tian F, Wen Z（并列一作）, Li J, Luo X, Deng L, Zhang L, He J, Yao F, Liao Z. Cost-effectiveness of Anbainuo plus methotrexate compared to conventional disease-modifying antirheumatic drugs for rheumatoid arthritis patients in China. Ann Transl Med. 2021. Jul;9(14):1165.
4、Wang G, Zhuo N, Tian F, Wen Z. Spinal gout with erector spinae muscle entrapment. Rheumatology (Oxford). 2021 Jul 14:keab549. doi: 10.1093/rheumatology/keab549.
5、Wang G, Zhuo N, Tian F, Wen Z, Andersson lesion in the lumbar spine of SAPHO syndrome. Rheumatology (Oxford). 2021 May 11:keab417. doi: 10.1093/rheumatology/keab417.
6、Wang G, Zhuo N, Luo X, Tian F, Wen Z, IgG4-Related Disease With Testicular Involvement: A Case Report and Review of Literature. Front Immunol. 2021 Aug 10;12:717902.
7、Wang G, Zhuo N, Liao Z, Qi W, Tian F, Wen Z, Retinal toxicity caused by hydroxychloroquine in patients with systemic lupus erythematosus: A case report. Medicine (Baltimore). 2021 Jun 4;100(22):e25688.
8、Tian F, Li J , Wen Z , et al. A novel etanercept biosimilar Anbainuo plus methotrexate exhibits increased cost-effectiveness compared to conventional disease-modifying anti-rheumatic drugs in treating rheumatoid arthritis patients.[J]. Medicine, 2019, 98(48):e17750.
9、Li J , Wen Z , Cai A , et al. Real-world cost–effectiveness of infliximab for moderate-to-severe rheumatoid arthritis in a medium-sized city of China[J]. Journal of Comparative Effectiveness Research, 2017, 06(3):205-218.
10、文振华, 李敬扬, 蒋会平,等. 类风湿关节炎患者颈椎失稳的发生率及相关危险因素分析[J]. 中华风湿病学杂志, 2016, 20(5):5.
11、文振华, 李敬扬, 罗筱雯,等. 类风湿关节炎合并抑郁状态的发生率及相关因素分析[J]. 中华风湿病学杂志, 2012, 16(2):4.
12、赵洪军,文振华.等.临床风湿免疫性疾病诊疗[M]. 吉林科学技术岀版社. 2019.
13、李敬扬, 文振华. 风湿病疑难病例解析[M]. 湖南科学技术出版社, 2013.
